indazoles has been researched along with riluzole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boireau, A; Bordier, F; Dubedat, P; Imperato, A; Moussaoui, S | 1 |
| Boczkowski, J; Desmonts, JM; Keita, H; Lang-Lazdunski, L; Lanone, S; Mantz, J; Rouellé, D; Samb, A | 1 |
| Dagci, T; Peker, G; Taskiran, D; Yilmaz, O | 1 |
| Artinian, L; Rehder, V; Yang, H; Zhong, L | 1 |
| Chen, S; Cohen-Sola, KA; Goydos, JS; Jeong, BS; Koo, J; Li, J; Lin, Y; Mehnert, JM; Shin, SS; Wen, Y | 1 |
5 other study(ies) available for indazoles and riluzole
| Article | Year |
|---|---|
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Indazoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease, Secondary; Riluzole | 2000 |
Anesthetic concentrations of riluzole inhibit neuronal nitric oxide synthase activity, but not expression, in the rat hippocampus.
Topics: Actins; Anesthetics; Animals; Enzyme Inhibitors; Hippocampus; Indazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Riluzole | 2000 |
Neuroprotective agents: is effective on toxicity in glial cells?
Topics: Animals; Anticonvulsants; Cells, Cultured; Drug Interactions; Glutamic Acid; Indazoles; L-Lactate Dehydrogenase; Melatonin; Neuroglia; Neuroprotective Agents; Nitrates; Rats; Rats, Sprague-Dawley; Riluzole | 2007 |
Nitric oxide as intracellular modulator: internal production of NO increases neuronal excitability via modulation of several ionic conductances.
Topics: Action Potentials; Animals; Apamin; Calcium Channels; Citrulline; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Guanylate Cyclase; Indazoles; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Potassium Channel Blockers; Receptors, Cytoplasmic and Nuclear; Riluzole; Small-Conductance Calcium-Activated Potassium Channels; Snails; Sodium Channel Blockers; Sodium Channels; Soluble Guanylyl Cyclase; Thiourea | 2012 |
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Heterocyclic Compounds, 3-Ring; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Inhibitor of Apoptosis Proteins; Interleukin-8; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Metabotropic Glutamate; Riluzole; Signal Transduction; Sirolimus; Skin Neoplasms; Survivin; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |